A detailed history of Golden State Equity Partners transactions in Medtronic PLC stock. As of the latest transaction made, Golden State Equity Partners holds 901 shares of MDT stock, worth $77,675. This represents 0.04% of its overall portfolio holdings.

Number of Shares
901
Holding current value
$77,675
% of portfolio
0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$76.84 - $91.03 $69,232 - $82,018
901 New
901 $81,000
Q4 2023

Feb 02, 2024

SELL
$69.43 - $83.43 $243,699 - $292,839
-3,510 Reduced 24.25%
10,963 $903,000
Q3 2023

Oct 20, 2023

BUY
$78.22 - $90.4 $422,153 - $487,888
5,397 Added 59.46%
14,473 $1.13 Million
Q2 2023

Jul 19, 2023

SELL
$79.47 - $91.38 $89,960 - $103,442
-1,132 Reduced 11.09%
9,076 $799,000
Q1 2023

Jun 01, 2023

SELL
$76.72 - $87.58 $579,082 - $661,053
-7,548 Reduced 42.51%
10,208 $823 Million
Q1 2022

May 18, 2022

BUY
$100.58 - $112.38 $928,252 - $1.04 Million
9,229 Added 108.23%
17,756 $1.97 Million
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $857,645 - $958,264
8,527 New
8,527 $1.01 Million
Q4 2021

Feb 11, 2022

SELL
$99.53 - $127.75 $1.07 Million - $1.37 Million
-10,722 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $14,975 - $16,490
122 Added 1.15%
10,722 $1.34 Million
Q2 2021

Aug 12, 2021

BUY
$118.19 - $131.5 $245,007 - $272,599
2,073 Added 24.31%
10,600 $1.32 Million
Q1 2021

May 13, 2021

BUY
$111.18 - $119.74 $255,714 - $275,402
2,300 Added 36.94%
8,527 $1.01 Million
Q4 2020

Feb 08, 2021

BUY
$100.57 - $117.14 $626,249 - $729,430
6,227 New
6,227 $729,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.